1 – 10 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance : a population-based study
(
- Contribution to journal › Article
- 2015
-
Mark
Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival.
(
- Contribution to journal › Letter
- 2014
-
Mark
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.
(
- Contribution to journal › Article
- 2012
-
Mark
Familial Aggregation of Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia with Solid Tumors and Myeloid Malignancies
(
- Contribution to journal › Scientific review
-
Mark
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
(
- Contribution to journal › Article
- 2011
-
Mark
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)
(
- Contribution to journal › Article
-
Mark
Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study
(
- Contribution to journal › Article
- 2010
-
Mark
Immune-Related and Inflammatory Conditions and Risk of Lymphoplasmacytic Lymphoma or Waldenstrom Macroglobulinemia.
(
- Contribution to journal › Article
-
Mark
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
(
- Contribution to journal › Article
- 2009
-
Mark
Highly increased familial risks for specific lymphoma subtypes
(
- Contribution to journal › Article